A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

In trials, a vaccine for pancreatic cancer developed by Sloan-Ketterin and BioNTech showed promise, but researchers say it is ...

A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study ...

There is new hope in the fight against pancreatic cancer after early trials showed that personalized mRNA vaccines can target ...

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...

"GMA" examines a preliminary study where a personalized mRNA vaccine showed promise in reducing the risk of pancreatic cancer ...

Researchers have developed a simple blood test to detect pancreatic cancer before it spreads to other sites in the body. The ...

Toni Bravo thought she was having an anxiety attack a couple weeks before finals at the University of Notre Dame last year.